BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 22883375)

  • 1. Dietary supplements for benign prostatic hyperplasia: an overview of systematic reviews.
    Kim TH; Lim HJ; Kim MS; Lee MS
    Maturitas; 2012 Nov; 73(3):180-5. PubMed ID: 22883375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phytotherapy for benign prostatic hyperplasia.
    Wilt TJ; Ishani A; Rutks I; MacDonald R
    Public Health Nutr; 2000 Dec; 3(4A):459-72. PubMed ID: 11276294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer.
    Cicero AFG; Allkanjari O; Busetto GM; Cai T; Larganà G; Magri V; Perletti G; Robustelli Della Cuna FS; Russo GI; Stamatiou K; Trinchieri A; Vitalone A
    Arch Ital Urol Androl; 2019 Oct; 91(3):. PubMed ID: 31577095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serenoa repens for benign prostatic hyperplasia.
    Wilt T; Ishani A; Mac Donald R
    Cochrane Database Syst Rev; 2002; (3):CD001423. PubMed ID: 12137626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pygeum africanum for benign prostatic hyperplasia.
    Wilt T; Ishani A; Mac Donald R; Rutks I; Stark G
    Cochrane Database Syst Rev; 2002; 1998(1):CD001044. PubMed ID: 11869585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cernilton for benign prostatic hyperplasia.
    Wilt T; Mac Donald R; Ishani A; Rutks I; Stark G
    Cochrane Database Syst Rev; 2000; (2):CD001042. PubMed ID: 10796739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutrition and benign prostatic hyperplasia.
    Espinosa G
    Curr Opin Urol; 2013 Jan; 23(1):38-41. PubMed ID: 23202286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WITHDRAWN: Cernilton for benign prostatic hyperplasia.
    Wilt TJ; Macdonald R; Ishani A; Rutks I; Stark G
    Cochrane Database Syst Rev; 2011 May; 2011(5):CD001042. PubMed ID: 21563128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serenoa repens and benign prostatic hyperplasia: no more effective than placebo.
    Prescrire Int; 2010 Aug; 19(108):181-2. PubMed ID: 20941857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicentric, placebo-controlled, double-blind clinical trial of beta-sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia. German BPH-Phyto Study group.
    Klippel KF; Hiltl DM; Schipp B
    Br J Urol; 1997 Sep; 80(3):427-32. PubMed ID: 9313662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phytotherapeutic agents in the treatment of benign prostatic hyperplasia.
    Dreikorn K
    Curr Urol Rep; 2000 Aug; 1(2):103-9. PubMed ID: 12084323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phytotherapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia.
    Dedhia RC; McVary KT
    J Urol; 2008 Jun; 179(6):2119-25. PubMed ID: 18423748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Extract of Serenoa repens in the treatment of benign prostatic hyperplasia and lower urinary tract symptoms].
    Amdii RE; Al' Shukri AS
    Urologiia; 2018 May; (2):114-120. PubMed ID: 29901305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herbal medications in the treatment of benign prostatic hyperplasia (BPH).
    Fagelman E; Lowe FC
    Urol Clin North Am; 2002 Feb; 29(1):23-9, vii. PubMed ID: 12109350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phytotherapy for benign prostatic hyperplasia.
    Gerber GS
    Curr Urol Rep; 2002 Aug; 3(4):285-91. PubMed ID: 12149159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serenoa repens (saw palmetto): a systematic review of adverse events.
    Agbabiaka TB; Pittler MH; Wider B; Ernst E
    Drug Saf; 2009; 32(8):637-47. PubMed ID: 19591529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phytotherapy of benign prostatic hyperplasia. A minireview.
    Pagano E; Laudato M; Griffo M; Capasso R
    Phytother Res; 2014 Jul; 28(7):949-55. PubMed ID: 25165780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serenoa repens for benign prostatic hyperplasia.
    Wilt T; Ishani A; Stark G; MacDonald R; Mulrow C; Lau J
    Cochrane Database Syst Rev; 2000; (2):CD001423. PubMed ID: 10796790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy of Serenoa repens treatment in patients with mild and moderate symptomatic benign prostatic hyperplasia.
    Sinescu I; Geavlete P; Multescu R; Gangu C; Miclea F; Coman I; Ioiart I; Ambert V; Constantin T; Petrut B; Feciche B
    Urol Int; 2011; 86(3):284-9. PubMed ID: 21304222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serenoa repens in benign prostatic hyperplasia].
    Log T
    Tidsskr Nor Laegeforen; 2008 May; 128(11):1293-4. PubMed ID: 18511974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.